StayWell Health Center OASIS
-
Services:
- In-network prescribing entity
- Private non-profit organization
- Discharge Planning
- Naloxone and overdose education
- Aftercare/continuing care
- Clients who have experienced intimate partner violence, domestic violence
- Clients who have experienced sexual abuse
- Clients with co-occurring mental and substance use disorders
- Clients who have experienced trauma
- Clients with HIV or AIDS
- Substance use disorder education
- HIV or AIDS education, counseling, or support
- Hepatitis education, counseling, or support
- Group counseling
- Health education services other than HIV/AIDS or hepatitis
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- Outreach to persons in the community
- Comprehensive mental health assessment
- Screening for tobacco use
- Screening for substance use
- Screening for mental disorders
- Comprehensive substance use assessment
- Young Adults
- Adults
- Clonidine
- Buprenorphine with naloxone
- Disulfiram
- Naltrexone (oral)
- Naltrexone (extended-release, injectable)
- Medication for mental disorders
- Non-nicotine smoking/tobacco cessation
- Buprenorphine without naloxone
- Smoking not permitted
- Regular outpatient treatment
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Opioid use disorder clients only
- Federally Qualified Health Center
- State department of health
- Vaping not permitted
- Mental health services
- Case management service
- Domestic violence services, including family or partner
- Transportation assistance
- Social skills development
- Suicide prevention services
- Integrated primary care services
- Early intervention for HIV
- Substance use treatment
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Male
- Female
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Drug and alcohol oral fluid testing
- This facility administers/prescribes medication for alcohol use disorder
- Buprenorphine detoxification
- Buprenorphine maintenance
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Prescribes naltrexone
- Prescribes buprenorphine
- Lofexidine or Clonidine detoxification
- Medicaid
- State-financed health insurance plan other than Medicaid
- Medicare
- Cash or self-payment
- Private health insurance
- Federal, or any government funding for substance use treatment programs
- SAMHSA funding/block grants
- Assistance with obtaining social services
- Housing services
- Employment counseling or training
- Payment assistance (check with facility for details)
- Sliding fee scale (fee is based on income and other factors)
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Substance use disorder counseling
- Relapse prevention
- Brief intervention
- Anger management
- Trauma-related counseling
- Matrix Model
- Motivational interviewing
- Telemedicine/telehealth therapy
- Cognitive behavioral therapy
External Source of Medications Used for Alcohol Use Disorder Treatment
Facility Operation (e.g., Private, Public)
Transitional Services
Special Programs/Groups Offered
Education and Counseling Services
Assessment/Pre-treatment
Age Groups Accepted
Pharmacotherapies
Facility Smoking Policy
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Exclusive Services
License/Certification/Accreditation
Facility Vaping Policy
Ancillary Services
Type of Care
Gender Accepted
Testing
Type of Alcohol Use Disorder Treatment
Type of Opioid Treatment
Payment/Insurance/Funding Accepted
Recovery Support Services
Payment Assistance Available
Opioid Medications used in Treatment
Treatment Approaches